Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

References

• GBD 2015 Chronic Respiratory Disease CollaboratorsGlobal, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of Disease Study 2015Lancet Respir Med20175969170628822787
   PubMed Web of Science ®Google Scholar
• SnellNStrachanDHubbardRGibsonJGruffydd-JonesKJarroldIS32 Epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British Lung Foundation’s ‘Respiratory Health of the Nation’ projectThorax201671Suppl 3A20
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease2018 Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdfAccessed January 15, 2019
   Google Scholar
• National Institute for Health and Care ExcellenceChronic obstructive pulmonary disease in over 16s: diagnosis and management2010 Available from: https://www.nice.org.uk/guidance/cg101Accessed January 15, 2019
   Google Scholar
• WurstKEShuklaAMuellerovaHDavisKJRespiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort studyCOPD201411552153024945236
   PubMedGoogle Scholar
• ChalmersJDTebbothAGayleATernouthARamscarNDeterminants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practiceNPJ Prim Care Respir Med20172714328663549
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInt J Chron Obstruct Pulmon Dis2015102207221726527869
   PubMed Web of Science ®Google Scholar
• HerrettEGallagherAMBhaskaranKData resource profile: clinical Practice Research Datalink (CPRD)Int J Epidemiol201544382783626050254
   PubMed Web of Science ®Google Scholar
• QuintJKMüllerovaHDisantostefanoRLValidation of chronic obstructive pulmonary disease recording in the clinical Practice Research Datalink (CPRD-GOLD)BMJ Open201447e005540e005540
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the medical Research Council (MRC) Dyspnoea Scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gold executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• RothnieKJMüllerováHThomasSLRecording of hospitalizations for acute exacerbations of COPD in UK electronic health care recordsClin Epidemiol2016877178227920578
   PubMed Web of Science ®Google Scholar
• RothnieKJMüllerováHHurstJRValidation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare recordsPLoS One2016113e015135726959820
   PubMed Web of Science ®Google Scholar
• NissenFMoralesDRMullerovaHSmeethLDouglasIJQuintJKValidation of asthma recording in the clinical Practice Research Data-link (CPRD)BMJ Open201778e017474
   Web of Science ®Google Scholar
• VestboJSørensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
   PubMed Web of Science ®Google Scholar
• PauwelsRALöfdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smokingN Engl J Med1999340251948195310379018
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
   PubMed Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCARamFSInhaled tiotropium for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20052CD002876
   Google Scholar
• CasaburiRBriggsDDJrDonohueJFSerbyCWMenjogeSSWitekTJThe spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US tiotropium Study GroupChest200011851294130211083677
   PubMed Web of Science ®Google Scholar
• LittnerMRIlowiteJSTashkinDPLong-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001614 Pt 11136114210764302
   PubMed Web of Science ®Google Scholar
• NiewoehnerDERiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med2005143531732616144890
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWISDOM InvestigatorsWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
   PubMed Web of Science ®Google Scholar
• RossiAGuerrieroMCorradoAOPTIMO/AIPO Study GroupWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Respir Res2014157725005873
   PubMed Web of Science ®Google Scholar
• RossiAvan der MolenTdel OlmoRInstead: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDEur Respir J20144461548155625359348
   PubMed Web of Science ®Google Scholar